Keywords: ginseng human umbilical vein endothelial cells vascular endothelial growth factor wound healing a b s t r a c t Background: Fermented black ginseng (FBG) is produced through several cycles of steam treatment of raw ginseng, at which point its color turns black. During this process, the original ginsenoside components of raw ginseng (e.g., Re, Rg1, Rb1, Rc, and Rb2) are altered, and less-polar ginsenosides are generated (e.g., Rg3, Rg5, Rk1, and Rh4). The aim of this study was to determine the effect of FBG on wound healing. Methods: The effects of FBG on tube formation and on scratch wound healing were measured using human umbilical vein endothelial cells (HUVECs) and HaCaT cells, respectively. Protein phosphorylation of mitogen-activated protein kinase was evaluated via Western blotting. Finally, the wound-healing effects of FBG were assessed using an experimental cutaneous wounds model in mice.
Introduction
Healing of a wound in the human tissue can be defined as a complex process that restores not only the anatomical integrity but also function by injury [1, 2] . The phases of wound healing include inflammation, proliferation, granulation tissue formation, re-growth of epithelial tissue, and remodeling of new tissue for the recovery of tissue integrity [3, 4] . Among these, the newly formed blood vessels play a crucial role in the formation of temporary granulation tissue and supply of oxygen and nutrients in replacement of tissues [5e7] . The expressions of proangiogenic growth factors, including fibroblast growth factor (FGF), transforming growth factor-b (TGF-b), vascular endothelial growth factor (VEGF), and angiopoietins, are important in wound angiogenesis [5] . VEGF is most essential in the initiation step of angiogenesis as it increases vascular permeability [8] as well as promotes endothelial cell proliferation and migration [9e11] . FGF-2, also called basic FGF, promotes endothelial cell differentiation and proliferation as a strong mitogenic factor [12, 13] . VEGF and FGF-2 act cooperatively to promote angiogenesis [14e16] . TGF-b regulates capillary tubule formation, endothelial cell migration, proliferation, and extracellular matrix deposition [17e19] .
Ginseng is one of the species of genus Panax which comprises several species of slow-growing perennial plants [20] . It is considered as one of the most important herbal medicine with various health benefits arising from consumption of the root and its extracts [21, 22] . The medicinal efficacies of ginseng identified by modern science include cancer prevention, analgesia, enhanced immune function, blood pressure normalization, enhanced liver function, anti-stress, anti-oxidative, and anti-fatigue effects, improved sexual functions, improved climacteric disorder, as well as anti-aging effects [23] . The active components of ginseng are ginsenosides which have a steroid-like structure and are divided into three types according to their aglycones: protopanaxadiol (PPD), protopanaxatriol, and oleanoic acid ginsenosides [24] . Fermented black ginseng (FBG) is produced through several cycles of steam treatment of raw ginseng, at which point its color turns black [25] . During this process, the original ginsenoside components of raw ginseng (e.g., Re, Rg1, Rb1, Rc, and Rb2) are altered and lesspolar ginsenosides are generated (e.g., Rg3, Rg5, Rk1, and Rh4) [26] .
In this study, we aim to assess the influence of FBG, which includes various bioactive ingredients, on wound healing by in vitro and in vivo experiments and to verify the possibility of using FBG as a wound healing medical ingredient.
Materials and methods

Reagents and chemicals
EZ-Cytox cell viability assay kit was obtained from ITSBIO (Seoul, Korea). Fetal bovine serum (FBS) was purchased from Invitrogen Co. (Grand Island, NY, USA). Primary antibodies for p38, extracellular signal-regulated kinase (ERK), phosphorylated-p38 (p-p38), and phosphorylated-ERK (p-ERK), and secondary antibodies were purchased from Cell Signaling Technology, Inc. (Danvers, MA, USA).
Preparation of ginseng extract and ginsenoside
Dried powder of FBG extract was provided by GINSENG BY PHARM Co., Ltd. (Wonju, Korea), which produced FBG extract by a recently reported method [27] . In brief, black ginseng was first generated after nine cycles of repeated steaming of raw ginseng at 85 C for 8 h. The produced black ginseng extract was further fermented with Saccharomyces cerevisiae (Lallemand, Denmark) at 34 C for 25 h. PPD, which is known to be effective in wound healing, was used as a positive control and was prepared as reported previously [22, 25] .
Analysis of ginsenosides
By using YL9100 HPLC system (Young-Lin, Anyang, Korea) fitted with a C-18, reversed-phase column (5 mm, 150 cm Â 4.6 mm i.d.;
YMC-Pack NH 2 , Kyoto, Japan) utilizing a solvent gradient system, ginsenoside samples were analyzed at a flow rate of 1 mL/min. The mobile phase consisted of 15% acetonitrile containing 5% acetic acid (solvent A) and 80% acetonitrile (solvent B). The model of evaporative light scattering detector was YL9180 (Young-Lin, Anyang, Korea). Gradient elution was carried out as follows: 0 min, 0% B; 6 min, 30% B; 18 min, 50% B; 30 min, 100% B; and 37 min, 100% B. Identification of ginsenosides was performed by the comparison of retention times with authentic samples (Table 1) .
Cell culture
Human umbilical vein endothelial cells (HUVECs) and HaCaT cells, an immortalized keratinocyte cell line from adult human skin, were purchased from ATCC (Manassas, VA, USA). HUVECs were cultured in Clonetics EGM-2 MV BulletKit (Lonza Inc., Walkersville, MD, USA) in a humidified atmosphere (5% CO 2 , 95% air). HaCaT cells were cultured using the media supplemented with penicillin (100 units/mL), streptomycin (100 mg/mL), and 10% FBS at 37 C (5% CO 2 , 95% air). The cells were passed on reaching about 70e80% confluence. The number of cells was calculated when cells were plated according to each experimental design.
Cell viability assay
The cytotoxicity of FBG and PPD to HUVECs and HaCaT cells was assessed using the EZ-Cytox cell viability assay. In brief, cells were seeded at a density of 2 Â 10 4 cells/mL in 96-well plates. The cells were then treated with various concentrations of FBG extract or PPD and incubated for 24 h at 37 C in a humidified atmosphere of 5% CO 2 and 95% air. After treatments, cell viability was measured according to manufacturer's instructions.
Tube formation assay
Cells were seeded (2.5 Â 10 5 cells/mL) onto the Matrigel-coated plate. Media, with or without sample, was added. The plates were then incubated at 37 C for 24 h. After incubation, the cells were fixed with 4% paraformaldehyde, followed by staining with Mayer's hematoxylin (Muto Pure Chemicals, Tokyo, Japan). Cell morphology changes and tubular-structure formation were observed using a light microscope. The degree of tube formation was quantified by measuring the lengths of the tubes in the images captured using the ImageJ program.
Western blotting analysis
HUVECs (8 Â 10 5 cells/mL) grown in 60 mm dishes were treated with the various concentrations of FBG extract (12.5 mg/mL and 25 mg/mL) for 24 h. Next, cell extracts were prepared using RIPA buffer (Cell Signaling, Danvers, MA, USA) that was supplemented with 1Â protease inhibitor cocktail and 1mM phenyl methyl sulfonyl fluoride. Proteins (30 mg/lane) were separated by electrophoresis, transferred onto polyvinylidene fluoride membranes, and allowed to bind with epitope-specific primary and secondary antibodies. Visualization of antibody bounding was confirmed using ECL Advance Western Blotting Detection Reagents (GE Healthcare, Buckinghamshire, UK) and a LAS 4000 imaging system (Fujifilm, Tokyo, Japan) following instruction manual.
Cell scratch wound healing assay in HaCaT cells
The scratch wound assay was assessed by cell migration after formation of scratch in the cell monolayer. Briefly, HaCaT cells were plated in 35-mm dish at a density of 8 Â 10 5 cells/mL. The following day, scratch wounds were formed in the HaCaT cell monolayer using a sterile pipette tip. The culture medium was changed with fresh serum-free medium and FBG (25 mg/mL) was added after washing away detached cells. After incubating for 12 h and 24 h, the wound width was measured at randomly chosen points under a light microscope equipped with a digital camera. The extent of wound closure was measured as the percentage compared to the original scratch width that had decreased at each measured time point.
Wound healing effect in an experimental cutaneous wounds model in mice
Animal testing regulations were approved by the animal research and ethics committee of Gachon University. 
Statistical analysis
Statistical significance was assessed using analysis of variance, followed by multiple comparison analysis with a Bonferroni adjustment. A p value of less than 0.05 was considered to be statistically significant.
Results and discussion
Wound healing progresses through the consecutive and synergistic remodeling phases that lack or overlap temporal distinction, including phases of inflammation, wound contraction, reepithelialization, and maturation. The inflammatory phase occurs in a few days after wounding, and inflammatory cells such as macrophages and leukocytes are the major participants [28, 29] . During the healing process that provides the delivery of nutrients and oxygen, angiogenesis is the most critical step. Angiogenesis is modulated by the expression of various vascular growth factors and modulators [30] . In this paper, we have demonstrated that FBG enhances angiogenesis in vitro and wound healing in vivo.
Analysis of ginsenosides in FBG extract
The HPLC profile of FBG extract is illustrated in Fig. 1 . A quantitative analysis revealed that FBG contains ginsenoside Re (0.09 mg/g), Rg1 (0.05 mg/g), and Rg3 (4.16 mg/g). Fig. 1 . Representative HPLC chromatogram of fermented black ginseng (FBG). Ginsenoside samples were analyzed using HPLC system fitted with a C-18 column utilizing a solvent gradient system. Identification of ginsenosides was performed by comparison of retention times with authentic samples.
Effects of the FBG and PPD on cell viability
Proliferation of cells such as endothelial cells and fibroblasts is essential for effective wound healing [11] . Therefore, we first investigated the effects of various concentrations of FBG and PPD on the viability of HUVECs using an MTT assay. As shown in Fig. 2A , FBG reduced the viability of HUVECs slightly in a treatment dosedependent manner. The cell viability (percent of control) ranged from 97.2 AE 2.56% (1.5625 mg/mL FBG) to 89.02 AE 1.49% (100 mg/mL FBG). At 100 mg/mL, FBG inhibited the viability of HUVECs by 10.98%. Compared with no effect with treatment of 25 mg/mL of FBG on HUVEC proliferation, cell viability was slightly decreased with the treatment of 50e100 mg/mL of FBG. As shown in Fig. 2B , the proliferation of HUVECs was reduced by PPD in a treatment dose-dependent manner. The cell viability (percent of control) ranged from 102.02 AE 1.79% (1.5625 mM PPD) to 16.34 AE 1.92% (100 mM PPD). PPD inhibited the viability of HUVECs by 83.66% at 100 mM concentration. Treatment with 12.5 mM PPD exerted no effect on HUVEC viability, whereas treatment with 25e100 mM inhibited its cell viability.
Effects of FBG and PPD on tube formation in HUVECs
The effect of non-toxic concentrations of FBG and PPD was tested on tube formation in HUVECs. FBG (doses of 12.5 mg/mL and 25 mg/ mL) and PPD (doses of 6.25 mM and 12.5 mM) were used to test their effects on the tube formation in HUVECs (Figs. 2C and 2D ). As shown in Fig. 2D , treatment with FBG and PPD increased tube formation, as estimated by the number of branching points. FBG (12.5 mg/mL) and PPD (12.5 mM) increased the tube formation by 20.3% and 29.53%, respectively, compared with the control cells. The phosphorylation of p38 and ERK has been suggested to be critical for tube formation. To determine the involvement of the pathways, the cells were treated with specific inhibitors of p38 (SB203580) and ERK (U0126). These inhibitors suppressed the enhancement of tube formation in the presence of FBG (Fig. 2C and 2D ).
Effects of FBG on angiogenic protein expression in HUVECs
The activation of p38 and ERK mitogen-activated protein kinases (MAPKs) signaling proteins are known to be involved in the main signaling pathways for migration and proliferation of endothelial cells [31, 32] . Therefore, we investigated the effects of FBG on the phosphorylation of ERK and p38 MAPKs. Western blotting analysis was performed to explore the effect of FBG on the activation of MAPK signaling pathway in HUVECs (Fig. 3A) . As quantified in Fig. 3B , the Western blot analysis showed that the levels of VEGF (1.71 AE 0.02 and 2.08 AE 0.03 fold at 12.5 mg/mL and 25 mg/mL FBG, respectively), p-p38 (1.54 AE 0.03 and 1.79 AE 0.02 fold at 12.5 mg/mL and 25 mg/mL FBG, respectively), and p-ERK (1.24 AE 0.01 and 1.57 AE 0.03 fold at 12.5 mg/mL and 25 mg/mL FBG, respectively) were markedly increased in the cells treated with FBG as compared to the non-treated control cells. The phosphorylation of p38 stimulated with FBG was completely inhibited by SB203580 (Fig. 3B) . In addition, the treatments of specific inhibitors for ERK (U0126) decreased the phosphorylation of ERK. However, the phosphorylation of ERK by treatment with FBG was upregulated in the presence of SB203580 (Fig. 3B) . 
Effects of FBG on cell scratch wound healing and proliferation in HaCaT cells
The effect of FBG on the scratch wound healing in HaCaT cells was tested using a cell-based wound healing model in which scratch wounds were formed in the HaCaT cell monolayer (Fig. 4A) .
The repaired percentage of scarification in the presence of 25 mg/mL of FBG was 45.8% at 24 h (Fig. 4B) . However, various concentrations of FBG had no toxic effects on HaCaT cell proliferation (Fig. 4C) . Scratch wounds in the culture containing FBG was inhibited with U0126 and SB203580 (Figs. 4A and 4B) . From these findings, we concluded that U0126 and SB203580 suppress the phosphorylation of ERK and p38, respectively, resulting in an apparent decrease of wound healing.
Effects of FBG on an experimental cutaneous wounds model in mice
Considering that FBG has significant effects in promoting migration and tube formation of HUVECs and HaCaT cells, we further employed an experimental cutaneous wounds model in mice to verify whether topical application of FBG may modify the (Fig. 5B) .
From the cell-based assays, it is evident that FBG increased the HUVEC proliferation, tube formation, and cell migration of HaCaT cells. FBG exerted significant angiogenic potential, which is associated with phosphorylation of ERK and p38. Furthermore, in vivo assays showed that FBG accelerates the process of wound healing in experimental cutaneous wounds model in mice. Based on these data, we conclude that FBG is a potent promoter of wound repair. 
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